Stockscreener 앱 받기
42.78
0.49%
0.235
전일 마감가:
$42.55
열려 있는:
$41.9
하루 거래량:
83,863
Relative Volume:
0.17
시가총액:
$2.30B
수익:
$226.84M
순이익/손실:
$3.55M
주가수익비율:
611.21
EPS:
0.07
순현금흐름:
$-12.02M
1주 성능:
-1.34%
1개월 성능:
+3.54%
6개월 성능:
-22.13%
1년 성능:
-5.05%
1일 변동 폭
$41.54
$42.77
1주일 범위
$40.53
$43.57
52주 변동 폭
$37.39
$63.00
베리셀 Stock (VCEL) Company Profile
명칭
Vericel Corp
전화
(734) 930-5555
주소
64 SIDNEY ST., CAMBRIDGE, MA
VCEL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VCEL
Vericel Corp
|
42.66 | 2.30B | 226.84M | 3.55M | -12.02M | 0.07 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.90 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
542.36 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
318.33 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
559.15 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
242.56 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
베리셀 Stock (VCEL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-08-09 | 개시 | Canaccord Genuity | Buy |
| 2024-06-20 | 개시 | TD Cowen | Buy |
| 2024-01-25 | 업그레이드 | Truist | Hold → Buy |
| 2023-08-08 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2022-11-10 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2022-11-09 | 다운그레이드 | Truist | Buy → Hold |
| 2022-10-14 | 재개 | Stephens | Overweight |
| 2021-01-11 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-12-18 | 개시 | Stephens | Overweight |
| 2020-09-17 | 개시 | Truist | Buy |
| 2019-10-09 | 개시 | H.C. Wainwright | Buy |
| 2019-02-28 | 다운그레이드 | Needham | Buy → Hold |
| 2018-08-08 | 재확인 | Needham | Buy |
| 2018-07-16 | 업그레이드 | Ladenburg Thalmann | Neutral → Buy |
| 2018-04-04 | 개시 | Leerink Partners | Outperform |
| 2018-03-06 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2018-03-06 | 재확인 | Needham | Buy |
| 2018-03-05 | 재확인 | BTIG Research | Buy |
| 2017-06-21 | 개시 | BTIG Research | Buy |
| 2017-03-13 | 재확인 | Needham | Buy |
| 2016-12-22 | 개시 | Piper Jaffray | Overweight |
| 2016-11-09 | 재확인 | Needham | Buy |
| 2016-04-05 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2016-03-11 | 업그레이드 | Needham | Hold → Buy |
모두보기
베리셀 주식(VCEL)의 최신 뉴스
Vericel at 2025 Truist Securities MedTech Conference: Growth Strategies Unveiled - Investing.com India
Vericel (NASDAQ:VCEL) Given “Overweight” Rating at Stephens - Defense World
Vericel (VCEL): Analyst Reiterates Overweight Rating with Stable Price Target | VCEL Stock News - GuruFocus
Handelsbanken Fonder AB Has $914,000 Holdings in Vericel Co. (NASDAQ:VCEL) - Defense World
Vericel Co. (NASDAQ:VCEL) Shares Sold by Rhumbline Advisers - Defense World
Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 17, 2025 - Yahoo Finance
GAMMA Investing LLC Acquires 127,028 Shares of Vericel Co. (NASDAQ:VCEL) - Defense World
Vericel Co. (NASDAQ:VCEL) Given Average Recommendation of “Buy” by Analysts - Defense World
3,924 Shares in Vericel Co. (NASDAQ:VCEL) Bought by Mackenzie Financial Corp - Defense World
Canaccord Genuity reiterates Buy rating on Vericel stock with $61 target - Investing.com
Bank of America Corp DE Sells 1,579 Shares of Vericel Co. (NASDAQ:VCEL) - Defense World
Vericel’s (VCEL) Overweight Rating Reiterated at Stephens - Defense World
What Analysts Are Saying About Vericel Stock - Benzinga
Vericel (VCEL) Maintains Overweight Rating by Stephens & Co. | V - GuruFocus
Vericel Co. (NASDAQ:VCEL) Shares Purchased by Deutsche Bank AG - Defense World
Vericel Co. (NASDAQ:VCEL) Stock Position Cut by BNP Paribas Financial Markets - Defense World
Truist maintains Buy on Vericel shares with $52 target By Investing.com - Investing.com India
Truist maintains Buy on Vericel shares with $52 target - Investing.com
VCEL to Be Featured in Upcoming Investor Meetings | VCEL Stock N - GuruFocus
Brokerages Set Vericel Co. (NASDAQ:VCEL) Price Target at $60.86 - Defense World
Vericel at BofA Securities Conference: Growth and Innovation in Healthcare By Investing.com - Investing.com India
Vericel at BofA Securities Conference: Growth and Innovation in Healthcare - Investing.com Australia
Transcript : Vericel Corporation Presents at BofA Securities 2025 Healthcare Conference, May-14-2025 09 - marketscreener.com
VCEL: Upcoming Meeting and Market Insights | VCEL Stock News - GuruFocus
First Trust Advisors LP Lowers Stock Holdings in Vericel Co. (NASDAQ:VCEL) - Defense World
Vericel Co. (NASDAQ:VCEL) Shares Sold by Tower Research Capital LLC TRC - Defense World
Vericel Corporation (NASDAQ:VCEL) Q1 2025 Earnings Call Transcript - Insider Monkey
Vericel (VCEL) Maintains Buy Rating Despite Target Price Adjustm - GuruFocus
Vericel (VCEL) Maintains Buy Rating Despite Target Price Adjustment | VCEL Stock News - GuruFocus
Vericel Corp (VCEL) Q1 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ... - Yahoo Finance
Vericel Corp Ord earnings missed by $0.10, revenue fell short of estimates - Investing.com India
Decoding Vericel Corp (VCEL): A Strategic SWOT Insight - GuruFocus
Earnings call transcript: Vericel Corp Q1 2025 sees revenue growth, stock steady - Investing.com India
Vericel Q1 2025 slides: record revenue offset by widening losses, raises guidance - Investing.com South Africa
Vericel Corporation Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
Vericel (VCEL) Reports Slightly Lower Than Expected Q1 Revenue | VCEL Stock News - GuruFocus
Vericel's Q1 Loss Widens, Revenue Rises; 2025 Revenue Growth Outlook Reiterated - marketscreener.com
VCEL Updates Revenue and Profitability Outlook for 2023 | VCEL Stock News - GuruFocus
Vericel Corporation (VCEL) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
Vericel Corp SEC 10-Q Report - TradingView
Vericel Corporation (VCEL): Among Stocks with Insanely High PE Ratios Insiders Are Selling - Insider Monkey
Vericel Corp Reports Q1 2025 Earnings: EPS of -$0.23 Misses Estimates, Revenue of $52.6M Below Expectations - GuruFocus
Vericel Corporation Q1 2025 Financial Results - TradingView
Earnings Flash (VCEL) VERICEL CORPORATION Reports Q1 Revenue $52.6M, vs. FactSet Est of $53.8M - marketscreener.com
Hsbc Holdings PLC Invests $405,000 in Vericel Co. (NASDAQ:VCEL) - The AM Reporter
Earnings To Watch: Vericel Corp (VCEL) Reports Q1 2025 Result - GuruFocus
Vericel to Present at the Bank of America Securities 2025 Healthcare Conference on Wednesday, May 14, 2025 - Barchart.com
Vericel’s 36% drop confirms InvestingPro’s January overvaluation warning By Investing.com - Investing.com
Vericel shareholders approve key incentive plans - Investing.com
Financial Health Report: Vericel Corp (VCEL)’s Ratios Tell a Tale - DWinneX
VCEL underperforms with a -0.26 decrease in share price - uspostnews.com
베리셀 (VCEL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
베리셀 주식 (VCEL) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Hopper Jonathan Mark | Chief Medical Officer |
Jun 02 '25 |
Sale |
40.09 |
10,000 |
400,900 |
66,237 |
1.21%
2.91%
자본화:
|
볼륨(24시간):